| Three broken parallel horizontal lines in a diamond shape Affinia Therapeutics Inc.
2074540 12 Nov 2020 | on 31 Dec 1969 | Class 005 Class 005 Pharmaceutical Products Gene therapy products, namely biopharmaceutical preparations, primarily comprised of adeno-associated virus (AAV) vectors comprising a transgene for delivery to a cell or tissue, for the treatment of rare genetic diseases, conditions and disorders of muscle and the central nervous system, namely, diseases, disorders, infections, and conditions of the central nervous system, namely brain, movement, and ocular motility diseases, neurodegenerative diseases, spinal cord diseases, brain diseases, muscle degeneration, muscle weakness and paralysis; biological preparations for medical, therapeutic and clinical gene therapy, namely, biopharmaceutical preparations, primarily comprised of adeno-associated virus (AAV) vectors comprising a transgene for delivery to a cell or tissue for the treatment of rare genetic diseases, conditions and disorders of muscle and the central nervous system, namely, diseases, disorders, infections, and conditions of the central nervous system, namely brain, movement, and ocular motility diseases, neurodegenerative diseases, spinal cord diseases, brain diseases, muscle degeneration, muscle weakness and paralysis. | |